Skip to main content

Table 1 Weight-related and plasma measurements of male Wistar rats after 8 weeks of dietary treatments

From: Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet

 

Male dietary groups

C (n = 7)

HFS (n = 9)

HFSsupp (n = 8)

ANOVA

Weight-related measurements

Weight gain (g)

152.6 ± 7.3a

191.8 ± 13.0b

198.8 ± 14.0b

*

Subcutaneous WAT (%)

1.89 ± 0.09a

3.14 ± 0.19b

3.10 ± 0.13b

***

Retroperitoneal WAT (%)

2.83 ± 0.25a

3.65 ± 0.16b

3.72 ± 0.21b

*

Epididymal WAT (%)

2.32 ± 0.20a

3.10 ± 0.11b

3.32 ± 0.20b

**

Mesenteric WAT (%)

1.06 ± 0.11a

1.45 ± 0.09b

1.45 ± 0.13b

*

Liver (%)

2.32 ± 0.03a

2.37 ± 0.06a

2.25 ± 0.05a

ns

Gastrocnemius muscle (%)

0.54 ± 0.02a

0.51 ± 0.01a

0.51 ± 0.01a

ns

Plasma values

Glucose (mg/dL)

114.5 ± 5.3a

134.0 ± 4.7b

122.9 ± 5.4a,b

*

HDL cholesterol (mg/dL)

69.2 ± 3.8a

72.0 ± 2.8a

79.6 ± 3.0a

ns

Triglycerides (mg/dL)

108.4 ± 8.8a

100.0 ± 11.3a

103.1 ± 9.6a

ns

Lactate (mg/dL)

25.6 ± 3.2a,b

32.8 ± 3.2a

22.1 ± 1.1b

*

Homocysteine (μmol/L)

17.9 ± 1.0a

18.7 ± 3.1a

14.3 ± 1.0a

ns

Insulin (μU/mL)

20.3 ± 2.4a

43.1 ± 5.0b

46.7 ± 3.6b

***

  1. All the results are expressed as the mean ± SE. Statistical analyses were performed using one-way Anova and Tukey post hoc test. Different letters (a, b) indicate significant differences between groups of at least p < 0.05
  2. WAT white adipose tissue, C control group, HFS high-fat-sucrose group, HFSsupp high-fat-sucrose supplemented with methyl donors group, ns non statistically significant
  3. * p < 0.05, ** p < 0.01, *** p < 0.001